264 related articles for article (PubMed ID: 36898083)
1. How I treat erythropoietic protoporphyria and X-linked protoporphyria.
Leaf RK; Dickey AK
Blood; 2023 Jun; 141(24):2921-2931. PubMed ID: 36898083
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietic protoporphyria.
Lecha M; Puy H; Deybach JC
Orphanet J Rare Dis; 2009 Sep; 4():19. PubMed ID: 19744342
[TBL] [Abstract][Full Text] [Related]
3. Congenital erythropoietic porphyria and erythropoietic protoporphyria: Identification of 7 uroporphyrinogen III synthase and 20 ferrochelatase novel mutations.
Weiss Y; Balwani M; Chen B; Yasuda M; Nazarenko I; Desnick RJ
Mol Genet Metab; 2019 Nov; 128(3):358-362. PubMed ID: 30454868
[TBL] [Abstract][Full Text] [Related]
4. Genetic study in a Singaporean patient with erythropoietic protoporphyria.
Chuah SY; Tee SI; Pramono ZA; Theng CT
Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):269-71. PubMed ID: 22971195
[TBL] [Abstract][Full Text] [Related]
5. Prevention of murine erythropoietic protoporphyria-associated skin photosensitivity and liver disease by dermal and hepatic ferrochelatase.
Pawliuk R; Tighe R; Wise RJ; Mathews-Roth MM; Leboulch P
J Invest Dermatol; 2005 Jan; 124(1):256-62. PubMed ID: 15654982
[TBL] [Abstract][Full Text] [Related]
6. Neonatal bone marrow transplantation prevents liver disease in a murine model of erythropoietic protoporphyria.
Duchartre Y; Petit N; Moya C; Lalanne M; Dubus P; Verneuil Hd; Moreau-Gaudry F; Richard E
J Hepatol; 2011 Jul; 55(1):162-70. PubMed ID: 21145811
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietic Protoporphyria and X-Linked Protoporphyria: pathophysiology, genetics, clinical manifestations, and management.
Balwani M
Mol Genet Metab; 2019 Nov; 128(3):298-303. PubMed ID: 30704898
[TBL] [Abstract][Full Text] [Related]
8. Cholestyramine resin for erythropoietic protoporphyria with severe hepatic disease: a case report.
Yoo DJ; Lee HC; Yu E; Jin YJ; Shim JH; Kim KM; Lim YS; Chung YH; Lee YS; Suh DJ
Korean J Hepatol; 2010 Mar; 16(1):83-8. PubMed ID: 20375647
[TBL] [Abstract][Full Text] [Related]
9. Cimetidine for erythropoietic protoporphyria.
Heerfordt IM; Lerche CM; Wulf HC
Photodiagnosis Photodyn Ther; 2022 Jun; 38():102793. PubMed ID: 35245673
[TBL] [Abstract][Full Text] [Related]
10. Biochemical abnormality in erythropoietic protoporphyria: cause and consequences.
Bloomer JR; Wang Y; Singhal A; Risheg H
J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S36-40. PubMed ID: 16819399
[TBL] [Abstract][Full Text] [Related]
11. Experimental and approved treatments for skin photosensitivity in individuals with erythropoietic protoporphyria or X-linked protoporphyria: A systematic review.
Heerfordt IM; Lerche CM; Philipsen PA; Wulf HC
Biomed Pharmacother; 2023 Feb; 158():114132. PubMed ID: 36525819
[TBL] [Abstract][Full Text] [Related]
12. Illuminating Dersimelagon: A Novel Agent in the Treatment of Erythropoietic Protoporphyria and X-Linked Protoporphyria.
Madigan KE; Rudnick SR; Agnew MA; Urooj N; Bonkovsky HL
Pharmaceuticals (Basel); 2023 Dec; 17(1):. PubMed ID: 38256864
[TBL] [Abstract][Full Text] [Related]
13. Photosensitivity and acute liver injury in myeloproliferative disorder secondary to late-onset protoporphyria caused by deletion of a ferrochelatase gene in hematopoietic cells.
Goodwin RG; Kell WJ; Laidler P; Long CC; Whatley SD; McKinley M; Badminton MN; Burnett AK; Williams GT; Elder GH
Blood; 2006 Jan; 107(1):60-2. PubMed ID: 16150949
[TBL] [Abstract][Full Text] [Related]
14. Recognized and Emerging Features of Erythropoietic and X-Linked Protoporphyria.
Di Pierro E; Granata F; De Canio M; Rossi M; Ricci A; Marcacci M; De Luca G; Sarno L; Barbieri L; Ventura P; Graziadei G
Diagnostics (Basel); 2022 Jan; 12(1):. PubMed ID: 35054318
[TBL] [Abstract][Full Text] [Related]
15. Loss-of-function ferrochelatase and gain-of-function erythroid-specific 5-aminolevulinate synthase mutations causing erythropoietic protoporphyria and x-linked protoporphyria in North American patients reveal novel mutations and a high prevalence of X-linked protoporphyria.
Balwani M; Doheny D; Bishop DF; Nazarenko I; Yasuda M; Dailey HA; Anderson KE; Bissell DM; Bloomer J; Bonkovsky HL; Phillips JD; Liu L; Desnick RJ;
Mol Med; 2013 Apr; 19(1):26-35. PubMed ID: 23364466
[TBL] [Abstract][Full Text] [Related]
16. Late presentation of erythropoietic protoporphyria: case report and genetic analysis of family members.
Berroeta L; Man I; Goudie DR; Whatley SD; Elder GH; Ibbotson SH
Br J Dermatol; 2007 Nov; 157(5):1030-1. PubMed ID: 17711525
[TBL] [Abstract][Full Text] [Related]
17. Delta-aminolevulinic acid synthase 2 expression in combination with iron as modifiers of disease severity in erythropoietic protoporphyria.
Barman-Aksözen J; Halloy F; Iyer PS; Schümperli D; Minder AE; Hall J; Minder EI; Schneider-Yin X
Mol Genet Metab; 2019 Nov; 128(3):304-308. PubMed ID: 31076252
[TBL] [Abstract][Full Text] [Related]
18. Clinical, Biochemical, and Genetic Characterization of North American Patients With Erythropoietic Protoporphyria and X-linked Protoporphyria.
Balwani M; Naik H; Anderson KE; Bissell DM; Bloomer J; Bonkovsky HL; Phillips JD; Overbey JR; Wang B; Singal AK; Liu LU; Desnick RJ
JAMA Dermatol; 2017 Aug; 153(8):789-796. PubMed ID: 28614581
[TBL] [Abstract][Full Text] [Related]
19. Acquired erythropoietic protoporphyria: A systematic review of the literature.
Snast I; Kaftory R; Sherman S; Edel Y; Hodak E; Levi A; Lapidoth M
Photodermatol Photoimmunol Photomed; 2020 Jan; 36(1):29-33. PubMed ID: 31374130
[TBL] [Abstract][Full Text] [Related]
20. Liver disease and erythropoietic protoporphyria: a concise review.
Casanova-González MJ; Trapero-Marugán M; Jones EA; Moreno-Otero R
World J Gastroenterol; 2010 Sep; 16(36):4526-31. PubMed ID: 20857522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
